Kael-GenVax successfully deployed the world’s first therapeutic vaccine for pancreatic cancer

Published: 2014-09-17 09:13:55

Updated: 2014-09-17 09:13:55

The world’s first therapeutic vaccine for pancreatic cancer received approval for sales in Korea after passing the European clinical test

On September 15, the Ministry of Foods and Drug Safety (MFDS) announced to approve the new drug for pancreatic cancer treatment, Liavax Inj (Code GV1001), which was newly developed by Kael-GenVax’ as a pancreatic cancer vaccine.

The main ingredient of ‘Liav...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.